A new short course of treatment for HIV-associated cryptococcal meningitis is as effective at preventing deaths as the current longer recommended regimen but causes far fewer serious side effects, ...
"The results of this phase 3 [AMBITION-cm] trial make it clear that this approach is just as good as the current World Health Organization-recommended first-line treatment in preventing death," first ...
-The PLATFORM-CM trial is evaluating oteseconazole and other investigational products against the standard of care for treating cryptococcal meningitis "We are excited to initiate this important study ...
Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related death in sub-Saharan Africa. Whether a treatment regimen that includes a single high dose of liposomal ...
Please provide your email address to receive an email when new articles are posted on . A large study conducted in five African countries identified an easier and less toxic treatment for ...
In a recent study published in Nature Microbiology, researchers examined metabolite-drug-fungal interactions in the fungal meningitis pathogen Cryptococcus neoformans. Antibiotic resistance refers to ...
Cryptococcal meningitis causes about one in ten HIV-related deaths, according to a study of autopsies performed in Mozambique and Brazil and coordinated by the Barcelona Institute for Global Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results